U.S. and Europe markets show expanding opportunities for generative AI across patient recruitment, trial design and clinical development, while global market is projected to grow at a CAGR of 23.27% from 2026 to 2035.
U.S. and Europe markets show expanding opportunities for generative AI across patient recruitment, trial design and clinical development, while global market is projected to grow at a CAGR of 23.27% from 2026 to 2035.